Login

Alan Beasley, CEO, Hydroponics Company Ltd 00:00:00

Share On Facebook Share On Twitter

OnMarket IPO: The Hydroponics Company (ASX:THC) interview with Alan Beasley & Andrew Beehag

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
From Childhood Puzzles to Financial Planning: A Journey of Problem-Solving and Fulfillment
00:00:00
Well-recognized leader in Pathology and Immunology education/Andrew Lichtman, MD, PhD Professor of Pathology at Harvard Medical School
00:10:00
Swetha Ramachandran, fund manager at Global Equities Artemis, discusses market trends alongside insights on Microsoft's CEO Satya in a segment with Financial Advisors, Options Action, and ETF Street.
00:10:00
Extraordinary Diamond Recoveries Propel Momentum for Johnny's Mines at One-to-One Conference
00:10:00
Midnight Sun Mining: Unveiling Copper Opportunities in Zambia
00:10:00
The power of choice and the power of wait is sweet|Aidan Madigan Curtis,General Partner,Eclipse Ventures
00:10:00
The positive outlook for the business, how they have helped their clients deal with COVID-19 and the strategic ambitions for the group|Paul Watts,CEO,Rosslyn Data Technologies
00:10:00
Marc Halbfinger, CEO of PCCW Global speaks on the continuous advancements in technology,|Mr Li was appointed an Executive Director and the Chairman of PCCW
00:10:00
Investing in the first institutional round of investment for software and hardware companies|Charles Hudson,Managing Partner,Precursor Ventures
00:10:00
Update on Asante Gold: Refurbishment Progress and Future Production Expectations
00:10:00
Raphaël Sanchez President of Generix Group.
00:10:00
Dr. Saloni Wagh Discusses Supriya Lifescience's Growth Strategy and Market Leadership | Saloni Wagh, Director, Supriya Lifescience Limited.

© 2017 - Neuhu+